Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Francisco
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Concurrent Medication:
Allowed:
Pneumocystis prophylaxis.
Antiretroviral therapy, or other experimental protocols.
Antipyretics and analgesics as per the treating physician.
You may not be if
Co-existing Condition:
Patients with the following are excluded:
Unexplained fever.
Night sweats.
Unexplained anemia with hemoglobin \< 10 g percent or hematocrit less than 30 percent.
Hepatic transaminase elevations or total bilirubin values of \> 3 times normal.
Long-term (over 2 weeks) treatment with any drug with known significant anti-Mycobacterium avium complex (MAC) activity including isoniazid, ethambutol, rifampin, raffia, PAS, PZA, amikacin, streptomycin, ethionamide, viomycin, cycloserine, capreomycin, ciprofloxacin, imipenem, rifapentine, gentamicin, or penicillin.
Patients with the following are excluded:
Known hypersensitivity to clofazimine.
Mycobacterium avium complex (MAC) infection diagnosis at any site (except isolation from stool in asymptomatic patient).
Any of the following symptoms at the time of study entry:
Unexplained fever.
Night sweats.
Unexplained anemia with hemoglobin \< 10 percent or hematocrit less than 30 percent.
Hepatic transaminase elevations or total bilirubin values of \> 3 times normal.
Long-term (over 2 weeks) treatment with any drug with known significant anti-MAC activity.
Prior Medication:
Excluded:
Long-term (over 2 weeks) treatment with any drug with known significant anti-Mycobacterium avium complex (MAC) activity including isoniazid, ethambutol, rifampin, raffia, PAS, PZA, amikacin, streptomycin, ethionamide, viomycin, cycloserine, capreomycin, ciprofloxacin, imipenem, rifapentine, gentamicin, or penicillin.
Group 1:
AIDS patients with a first episode of Pneumocystis carinii pneumonia (PCP) within 2 to 4 months prior to study entry.
Group 2:
Patients with T4 counts \< 100 cells/mm3, regardless of prior opportunistic infections or malignancies.
